Literature DB >> 11532573

Stability of amorphous indomethacin compounded with silica.

T Watanabe1, N Wakiyama, F Usui, M Ikeda, T Isobe, M Senna.   

Abstract

The stability of indomethacin (IM) compounded with SiO(2) either by co-grinding or by melt-quenching was examined by recrystallization kinetics under the conditions 30 degrees C and 11% relative humidity. A decrease of the recrystallization rate with and without an appreciable induction period was observed in both compounds. Higher stability of amorphous IM compounded with SiO(2) was attained by prolonged co-grinding than by melt-quenching. This was explained by the stronger chemical interaction at the interface between IM and SiO(2) by co-grinding, as revealed by (29)Si and (13)C solid state NMR. Incomplete co-grinding with the rest of the crystalline state, however, made the amorphous state appreciably unstable, since the remaining crystallites serve as seeds for recrystallization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532573     DOI: 10.1016/s0378-5173(01)00776-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.

Authors:  Ambarish H Vadher; Jolly R Parikh; Rajesh H Parikh; Ajay B Solanki
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

2.  Elucidation of Compression-Induced Surface Crystallization in Amorphous Tablets Using Sum Frequency Generation (SFG) Microscopy.

Authors:  Pei T Mah; Dunja Novakovic; Jukka Saarinen; Stijn Van Landeghem; Leena Peltonen; Timo Laaksonen; Antti Isomäki; Clare J Strachan
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

3.  Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13.

Authors:  Shamkant L Shimpi; Bhaskar Chauhan; K R Mahadik; Anant Paradkar
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

4.  Solubility enhancement of rosiglitazone by using melt sonocrystallization technique.

Authors:  Vaibhavkumar A Jagtap; G Vidyasagar; S C Dvivedi
Journal:  J Ultrasound       Date:  2014-02-27

5.  Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

6.  Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules.

Authors:  Manish K Gupta; Yin-Chao Tseng; David Goldman; Robin H Bogner
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

7.  Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.

Authors:  Anshuman A Ambike; K R Mahadik; Anant Paradkar
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

8.  Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

9.  Solubility Enhancement of a Poorly Water Soluble Drug by Forming Solid Dispersions using Mechanochemical Activation.

Authors:  I Rojas-Oviedo; B Retchkiman-Corona; C T Quirino-Barreda; J Cárdenas; P S Schabes-Retchkiman
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

10.  Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities.

Authors:  Xin Xia; Kevin Pethe; Ryangyeo Kim; Lluis Ballell; David Barros; Jonathan Cechetto; HeeKyoung Jeon; Kideok Kim; Alfonso E Garcia-Bennett
Journal:  Nanomaterials (Basel)       Date:  2014-09-11       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.